Cover Image
市場調查報告書

無針傳輸技術的全球市場展望 (2018年∼2028年):高速氣壓注射器技術、競合技術 (新型有針技術、吸入器技術、經皮貼片技術)

Needle-Free Delivery Technology Market 2018-2028: Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology

出版商 Visiongain Ltd 商品編碼 233147
出版日期 內容資訊 英文 183 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
無針傳輸技術的全球市場展望 (2018年∼2028年):高速氣壓注射器技術、競合技術 (新型有針技術、吸入器技術、經皮貼片技術) Needle-Free Delivery Technology Market 2018-2028: Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology
出版日期: 2018年08月21日 內容資訊: 英文 183 Pages
簡介

世界無針藥劑傳輸 (Drug Delivery)市場規模在2017年達到17億美元,預計在2028年將會成長至55億美元,擁有11.5%的CAGR (複合年均增長率) 。2017年的現在,高速氣壓注射器佔了市場份額的45.1%。

本報告針對無針 (Needle Free) 傳輸的全球市場進行調查分析,統整了無針傳輸技術的必要性和優缺點、現在可使用的/開發中的主要產品 (高速氣壓注射器、競合技術) 的概要、市場規模的趨勢預測、各國市場的詳細趨勢、主要促進或抑制市場成長的因素、主要企業檔案、主力產品及業績預測,以及今後市場趨勢的方向等。

第1章 分析概要

第2章 無針傳輸技術的梗概

  • 什麼是無針 (Needle Free) 傳輸技術?
  • 無針傳輸技術市場
  • 無針傳輸技術發揮效用的臨床現場
    • 疼痛管理
    • 疫苗傳輸:改善免疫反應
    • 為糖尿病患者開發的胰島素傳輸
    • 小兒用注射
    • 其他使用法
  • 無針傳輸技術市場相關規範 (美國、歐洲)
  • 生物醫藥品

第3章 無針傳輸技術:全球市場

  • 市場概況
  • 各產品市場占比
  • 市場未來預測 (今後12年間)
  • 預測各部門市場占比變動
  • 今後市場趨勢
  • 促進或抑制市場成長的主要原因

第4章 高速氣壓注射器技術市場

  • 高速氣壓注射器技術:概要
  • 高速氣壓注射器技術:市場預測 (今後12年間)
  • 高速氣壓注射器的主要產品 (全15項產品)
  • 高速氣壓注射器的研發 (全7項產品)

第5章 競合的無針傳輸技術市場

  • 競合技術概要
  • 競合技術市場:未來預測 (今後11年間)
  • 競合技術市場:預測各部門市場占比變動
  • 新型有針技術:概要
  • 新型有針技術:市場預測 (今後11年間)
    • 主要產品 (全5項產品)
    • 研發產品 (全11項產品)
  • 吸入器技術:概要
  • 吸入器技術:市場預測 (今後12年間)
    • 氣喘用吸入器
      • 預防藥物吸入器
      • 緩解藥物吸入器
    • 胰島素用吸入器
    • 疫苗用吸入器
  • 經皮貼片技術:概要
  • 經皮貼片技術:市場預測 (今後12年間)
    • 主要的經皮貼片產品 (全4項產品)
    • 經皮貼片技術的研發 (全4項產品)
  • 開發中的其他競合技術 (全4項產品)

第6章 主要國家市場 (今後11年間)

  • 無針傳輸技術全球市場:地區別未來預測 (今後11年間)
    • 預測地區別市場占比變動
  • 美國市場
  • 歐洲主要5國市場 (EU5:德國、法國、英國、義大利、西班牙)
  • 日本市場
  • 中國市場
  • 印度市場
  • 其他國家 (RoW) 市場

第7章 無針傳輸技術的代表企業

  • 無針傳輸技術的主要廠商
  • Antares Pharma
  • Zogenix
  • 3M
  • Becton Dickinson and Company (BD)
  • PharmaJet
  • BioJect Medical Technologies

第8章 無針傳輸技術市場的定性研究

  • 無針傳輸技術的SWOT分析
  • 優勢
    • 生物醫藥品市場的大幅成長
    • 經皮傳輸技術的進步
    • 不須專門訓練、也不會發生意外
    • 避免冷鏈問題
  • 劣勢
    • 不習慣使用新型傳輸裝置的醫事人員
    • 強化規範與檢查
    • 無效率的製造工程
  • 機會
    • 在新興國市場的巨大成長機會
    • 在世界各地的集體預防接種計畫
    • 轉移至居家治療
    • 延長藥劑的生命週期
  • 威脅
    • 傳統注射針、注射器:以大量生產降低製造成本
    • 可預防意外的注射針、注射器
    • 臨床資料不足
    • 對醫療器材收取的物品稅

第9章 結論

  • 現在的主力部門
    • 應矚目的企業
    • 主要國家市場
  • 全球市場未來預測 (今後11年間)
  • 無針傳輸技術市場的未來樣貌
    • 生物仿製:無針傳輸技術市場的強力促進因素
    • 強力的研發產品:無針傳輸技術的促進因素

附錄

  • 用語集

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0327

The global needle-free delivery technology market was valued at $1.7bn in 2017 and is estimated to reach $5.5bn by 2028, growing at a CAGR of 11.5% from 2018-2028. In 2017, the Jet Injectors submarket held 45.1% of the global needle-free delivery technology market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 183-page report you will receive 107 charts - all unavailable elsewhere.

The 183-page report provides clear detailed insight into the global needle-free delivery technology market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Needle-Free Delivery Technology market forecasts from 2018-2028
  • Jet Injector submarket forecasts from 2018-2028
  • Competing Technology submarket forecast from 2018-2028, further segmented into:
    • Novel Needle Technology
    • Inhaler Technology
    • Patch Technology
  • This report also breaks down the revenue forecast for global needle-free delivery technology market by regional and national market:
    • The US
    • EU5: Germany, France, UK, Italy, Spain
    • Japan
    • China
    • India

image1

  • This report discusses the leading companies that are involved in the needle-free delivery technology market. It contains overviews of the companies' activities, strategies and recent financial results:
    • 3M
    • Antares Pharma
    • Becton Dickinson
    • BioJect Medical Technologies
    • PharmaJet
    • Zogenix
  • This report provides a SWOT Analysis of the global needle-free delivery technology market.

Visiongain's study is for everybody needing commercial analyses for the needle-free delivery technology market and leading companies. You will find data, trends and predictions. Please order our report now.

Table of Contents

1. Report Overview

  • 1.1 Global Needle-Free Delivery Technology Market Overview
  • 1.2 Global Needle-Free Delivery Technology Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 How This Report Delivers
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report For?
  • 1.7 Methodology
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to Needle-Free Delivery Technology

  • 2.1 What is Needle-Free Delivery Technology?
    • 2.1.1 Needlestick Injury
      • 2.1.1.1 Blood-Borne Pathogens and Needlestick Injury
      • 2.1.1.2 Accidental Needlestick Injury: A Serious Healthcare Problem
  • 2.2 The Needle-Free Delivery Technology Market
    • 2.2.1 Jet Injectors
      • 2.2.1.1 Concerns about Multi-use Nozzle Jet injectors (MUNJIs)
      • 2.2.1.2 Strengths and Weaknesses of Jet Injectors
    • 2.2.2 Competing Needle-Free Technologies
      • 2.2.2.1 Novel Needle Technology
      • 2.2.2.2 Pen Needles
      • 2.2.2.3 Microneedles
      • 2.2.2.4 Hollow Microneedles
      • 2.2.2.5 Solid Coated Microneedles
      • 2.2.2.6 Solid Biodegradable Microneedles
      • 2.2.2.7 Solid Uncoated Microneedles
      • 2.2.2.8 Using the Right Microneedles
      • 2.2.2.9 Inhaler Technology
      • 2.2.2.10 Transdermal Patch Technology
  • 2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
    • 2.3.1 Pain Management
      • 2.3.1.1 Using Needle-Free Injection Devices to Administer Lidocaine
    • 2.3.2 Vaccine Delivery: Improving Immune Response
      • 2.3.2.1 Needle-Free Vaccine Delivery
      • 2.3.2.2 Mass Immunisation
    • 2.3.3 Insulin Delivery for Diabetics
    • 2.3.4 Paediatric Injections
    • 2.3.5 Other Uses for Needle-Free Injection Technology
  • 2.4 Regulation of the Needle-Free Delivery Technology Market
    • 2.4.1 The US Regulation System
      • 2.4.1.1 Combination Products
      • 2.4.1.2 FDA Statement Clamps Down On Delivery of Medications in Non-Approved Needle-Free Devices
    • 2.4.2 The European Regulation System
      • 2.4.2.1 Post Marketing Surveillance in the EU
  • 2.5 Biopharmaceuticals
    • 2.5.1 An Introduction to the Biological Drugs Market
    • 2.5.2 Biologics: A Rising Drugs Market

3. Needle-Free Delivery Technology: Global Market 2018-2028

  • 3.1 The Needle-Free Delivery Technology Market: Overview
  • 3.2 Needle-Free Delivery Technology Market Segmentation, 2017
  • 3.3 The Needle-Free Delivery Technology Market Forecast, 2017-2028
  • 3.4 How Will Segmental Market Shares Change to 2028?
  • 3.5 Needle-Free Delivery Technology: Market Trends, 2018-2028
  • 3.6 Needle-Free Delivery Technology: Drivers and Restraints 2018-2028

4. Jet Injectors Technology Market, 2018-2028

  • 4.1 The Jet Injectors Market Overview
  • 4.2 Jet Injectors: Market Forecast 2017-2028
  • 4.3 Jet Injector Devices on the Market
    • 4.3.1 Biojector 2000 (Bioject Medical Technologies)
    • 4.3.2 ZetaJet (Bioject Medical Technologies)
    • 4.3.3 Vision (Antares Pharma)
    • 4.3.4 Vibex (Antares Pharma)
    • 4.3.5 Sumavel DosePro (Endo International)
    • 4.3.6 Stratis (PharmaJet)
    • 4.3.7 LectraJet (D'Antonio Consultants International)
    • 4.3.8 AdvantaJet and GentleJet (Activa Brand Products)
    • 4.3.9 Vitajet (Bioject Medical Technologies)
    • 4.3.10 Med-Jet (Medical International Technologies)
    • 4.3.11 J-Tip (National Medical Products)
    • 4.3.12 Injex30 (Injex Pharma)
    • 4.3.13 SQ-Pen, SQ-X and MHP-1 (Bespak)
    • 4.3.14 E-Jet 100 (Eurojet Medical)
    • 4.3.15 Penjet (Penjet Corporation)
  • 4.4 Jet Injectors Development Pipeline
    • 4.4.1 Glide SDI (Glide Pharmaceutical Technologies)
    • 4.4.2 Zeneo (Crossject)
    • 4.4.3 Relday (Zogenix)
    • 4.4.4 Magnetic Injection (Massachusetts Institute of Technology)
    • 4.4.5 Intradermal (ID) Pen (Bioject Medical Technologies)
    • 4.4.6 Iject and Iject R (Bioject Medical Technologies)
    • 4.4.7 Jupiter Jet (Bioject Medical Technologies)

5. Competing Needle-Free Technology Market, 2018-2028

  • 5.1 The Competing Needle-Free Technology Overview
  • 5.2 The Competing Technology: Market Forecast 2017-2028
  • 5.3 How Will Segmental Market Shares Change to 2028?
  • 5.4 Novel Needle Technology Overview
  • 5.5 Novel Needle Technology: Market Forecast, 2018-2028
    • 5.5.1 Leading Novel Needle Technologies
      • 5.5.1.1 Soluvia Microinjection System (BD)
      • 5.5.1.2 Ultra-Fine Nano 4mm Pen Needle (BD)
      • 5.5.1.3 AutoShield Duo Pen Needle (BD)
      • 5.5.1.4 Microstructured Transdermal Systems (3M)
      • 5.5.1.5 ZP Patch Technology (Zosano)
    • 5.5.2 Novel Needle Technology Development Pipeline
      • 5.5.2.1 Microneedle Patch (Georgia Institute of Technology)
      • 5.5.2.2 Micronjet (NanoPass)
      • 5.5.2.3 DebioJect (Debiotech)
      • 5.5.2.4 AdminPen (nanoBioSciences)
      • 5.5.2.5 PKA SoftTouch (PKA SoftTouch Corp)
      • 5.5.2.6 DrugMat and VaxMat (TheraJect)
      • 5.5.2.7 MicroCor (Corium International)
      • 5.5.2.8 Nanopatch (Vaxxas)
      • 5.5.2.9 Nanotopography Enhanced Microneedle Delivery (University of California-San Francisco, Georgia Institute of Technology and Kimberly-Clark)
      • 5.5.2.10 Memspatch and Micro-Patch (Nemaura)
      • 5.5.2.11 Microneedle Patch for Lidocaine Delivery (National University of Singapore)
  • 5.6 Inhaler Technology Overview
  • 5.7 Inhaler Technology: Market Forecast, 2017-2028
    • 5.7.1 Inhaler Products in the Asthma Market
      • 5.7.1.1 Preventer Inhalers
      • 5.7.1.2 Reliever Inhalers
    • 5.7.2 Inhaler Products in the Insulin Market
    • 5.7.3 Inhaler Products in the Vaccine Market: FluMist Quadrivalent (MedImmune)
      • 5.7.3.1 Pipeline
  • 5.8 Transdermal Patch Technology Overview
  • 5.9 Transdermal Patch Technology: Market Forecast, 2017-2028
    • 5.9.1 Selected Transdermal Patch Products
      • 5.9.1.1 Duragesic (Fentanyl, Janssen Pharmaceuticals)
      • 5.9.1.2 Nicoderm CQ (Nicotine, GlaxoSmithKline)
      • 5.9.1.3 Exelon Patch (Rivastigmine, Novartis)
      • 5.9.1.4 Zecuity (Sumatriptan, Teva)
    • 5.9.2 Transdermal Patch Technology Development Pipeline
      • 5.9.2.1 Electronic Transdermal Patch (Rhenovia Pharma)
      • 5.9.2.2 Electroporation-Mediated DNA Drug Delivery (TriGrid, Ichor Medical Systems)
      • 5.9.2.3 Ultrasonic Waveforms (U-Strip, Transdermal Specialties)
      • 5.9.2.4 Prelude SkinPrep System (Echo Therapeutics)
  • 5.10 Other Competing Needle-free delivery Technology in development
    • 5.10.1 Microbubbles Injection (Shibaura Institute of Technology)
    • 5.10.2 Laser Injection (Seoul National University)
    • 5.10.3 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
    • 5.10.4 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)

6. Leading National Markets 2017-2028

  • 6.1 Global Needle-Free Delivery Technology Market: Regional Forecast 2018-2028
    • 6.1.1 How Will Regional Market Shares Change to 2026?
  • 6.2 The US Needle-Free Delivery Technology Market 2018-2028
    • 6.2.1 US Needle-Free Delivery Technology Market Forecast 2018-2028
    • 6.2.2 FDA Guideline for Combination Products
    • 6.2.3 Needle-Free Delivery and the US Flu Vaccination Market
    • 6.2.4 Measles Outbreak in the US
  • 6.3 The EU5 Needle-Free Delivery Technology Market 2017-2028
    • 6.3.1 EU5 Needle-Free Delivery Technology Market Forecast 2018-2028
    • 6.3.2 Germany Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.3 France Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.4 The UK Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.5 Italy Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.6 Spain Needle-Free Delivery Technology Market Forecast, 2018-2028
  • 6.4 Japan Needle-Free Delivery Technology Market 2018-2028
    • 6.4.1 Japan Needle-Free Delivery Technology Market Forecast 2018-2028
  • 6.5 China Needle-Free Delivery Technology Market 2018-2028
    • 6.5.1 China Needle-Free Delivery Technology Market Forecast 2018-2028
  • 6.6 India Needle-Free Delivery Technology Market 2018-2028
    • 6.6.1 India Needle-Free Delivery Technology Market Forecast 2018-2028
    • 6.6.2 Needles and Syringes being Re-used in Indian Hospitals
  • 6.7 The Rest of the World (RoW) Needle-Free Delivery Technology Market 2018-2028
    • 6.7.1 RoW Needle-Free Delivery Technology Market Forecast 2018-2028

7. Leading Companies in the Needle-Free Delivery Technology Market

  • 7.1 Leading Needle-Free Delivery Technology Manufacturers in 2017
  • 7.2 Antares Pharma: Leading the Needle-Free Injector Market
    • 7.2.1 Antares Pharma: Needle-Free Technology Product Portfolio
    • 7.2.2 Antares Pharma: Future Outlook
    • 7.2.3 Antares Pharma: Products in Development
    • 7.2.4 Settlement of Patent Infringement Case between Antares Pharma and Medac Pharma
  • 7.3 Zogenix
    • 7.3.1 Zogenix: Product Portfolio
    • 7.3.2 Zogenix: Current Pipeline
    • 7.3.3 Zogenix: Financial Overview
  • 7.4 3M: 50 Years of Drug Delivery Technology Development
    • 7.4.1 3M: Drug Delivery Technology Portfolio
    • 7.4.1.1 Oral and Topical Drug Delivery
    • 7.4.1.2 MDI for Nasal and Inhalable Drugs
    • 7.4.1.3 Transdermal patch Technology
    • 7.4.1.4 Microneedle Technology
    • 7.4.2 3M: Market Outlook
  • 7.5 Becton Dickinson and Company (BD)
    • 7.5.1 BD: Drug Delivery Technology Portfolio
    • 7.5.1.1 Prefillable Syringe Systems
    • 7.5.1.2 Self-Injection Systems
    • 7.5.1.3 Pen Needles
    • 7.5.1.4 Safety & Shielding Systems
    • 7.5.2 BD: Future Outlook
    • 7.5.3 New Infusion Set with BD FlowSmart Technology Cleared by FDA
    • 7.5.4 BD Acquired Injection Safety Firms
    • 7.5.5 Recall of BD Needles in Hong Kong
  • 7.6 PharmaJet
    • 7.6.1 PharmaJet: Needle-Free Delivery Technology Product Portfolio
    • 7.6.2 First FDA Approved Jet Injector for Flu Shot in the US
    • 7.6.3 PharmaJet: Collaborations and Needle-Free Delivery Technology Pipeline
    • 7.6.4 Preference for PharmaJet over Needle and Syringe
  • 7.7 BioJect Medical Technologies
    • 7.7.1 Bioject Medical Technologies: Needle-Free Delivery Technology Product Portfolio and Pipeline
    • 7.7.2 Bioject Medical Technologies: Financial Overview
    • 7.7.3 Focusing on Developing Countries

8. Qualitative Analysis of the Needle-Free Delivery Technology Market 2017-2028

  • 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market
  • 8.2 Strengths
    • 8.2.1 Strong Growth in the Biologic Drug Market
    • 8.2.2 Increasing Development in Transdermal Delivery
    • 8.2.3 No Specialist Training Required and No Needlestick Injuries
    • 8.2.4 Eliminating the Cold Chain Problem
  • 8.3 Weaknesses
    • 8.3.1 Healthcare Practitioners are not familiar with Novel Delivery Systems
    • 8.3.2 Greater Regulatory Scrutiny
    • 8.3.3 Inefficient Manufacturing Processes
  • 8.4 Opportunities
    • 8.4.1 Emerging Economies Offer Significant Growth Opportunities
    • 8.4.2 Mass Immunisation Programmes around the World
    • 8.4.3 Increasing Global Diabetic Population
    • 8.4.4 Shift towards Home Administration Setting
    • 8.4.5 Extending Life Cycle of Drugs
  • 8.5 Threats
    • 8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce
    • 8.5.2 Needle and Syringes with Anti Needlestick Injury Technology
    • 8.5.3 Limited Clinical Data
    • 8.5.4 Medical Device Excise Tax

9. Conclusions

  • 9.1 Current Leading Needle-Free Technology Segments
    • 9.1.1 Notable Needle-Free Technology Companies
    • 9.1.2 Leading Regional Markets
  • 9.2 Global Needle-Free Technology Market Forecast 2018-2028
  • 9.3 The Future of the Needle-Free Technology Market
    • 9.3.1 Biosimilars are a Major Driver of the Needle-free Delivery Market
    • 9.3.2 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market

Appendices

  • Glossary
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Tables

  • Table 2.1 Classification of Jet Injectors by Method of Propulsion
  • Table 2.2 Strengths and Weaknesses of the Jet Injector Market
  • Table 2.3 Pen Needle Technology by Needle Length
  • Table 2.4 Rationale for Needle-Free Vaccine Delivery
  • Table 2.5 Examples of Needle-Free Vaccine Delivery Systems, 2017
  • Table 2.6 Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2017
  • Table 2.7 FDA Guidance on Regulation of Needle-Free Injectors, 2017
  • Table 2.8 Top 5 Biologics by Sales ($bn) in U.S, 2017
  • Table 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2017
  • Table 3.2 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 3.3 Needle-Free Delivery Market Segments: Market Size ($m) and Market Share (%), 2017, 2022 and 2028
  • Table 4.1 The Jet Injectors Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.1 The Competing Needle-Free Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.2 Market Size ($m) and Market Share (%) of Competing Needle-Free Technology Market Segments, 2017
  • Table 5.3 Novel Needle Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.4 Inhaler Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.5 Leading Products in the Asthma Preventer Inhaler Market, 2017
  • Table 5.6 Leading Products in the Asthma Reliever Inhaler Market, 2017
  • Table 5.7 Vaccine Inhalers Currently Under Development, 2017
  • Table 5.8 Transdermal Patch Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.9 Transdermal Patch Products, 2017
  • Table 6.1 Global Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%) by Region, 2017-2028
  • Table 6.2 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2017-2028
  • Table 6.3 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2017, 2022 and 2028
  • Table 6.4 US Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.5 EU5 Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.6 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2017, 2022 and 2028
  • Table 6.7 Germany Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.8 France Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.9 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2017-2028
  • Table 6.10 Italy Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.11 Spain Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.12 Japan Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.13 China Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2017-2028
  • Table 6.14 India Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.15 RoW Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 7.1 Antares Pharma: Overview, 2017
  • Table 7.2 Antares Pharma: 2017 Product Portfolio (Product, Drug, Partner, Indication and Territory
  • Table 7.3 Antares Revenue from Major Customers: Revenue ($m) and Revenue Share (%), 2016 and 2017
  • Table 7.4 Antares Revenue by Region: Revenue ($m) and Revenue Share (%), 2016 and 2017
  • Table 7.5 Antares Pharma: Historical Revenue ($m), AGR (%) and CAGR (%), 2013-2017
  • Table 7.6 Antares Pharma: Products in Development 2017 (Product Name, Drug, Partner, Indication, Territory and Regulatory Status)
  • Table 7.7 Zogenix: Overview, 2017
  • Table 7.8 Zogenix: Revenue ($m), AGR (%) and CAGR (%), 2013-2017
  • Table 7.9 Zogenix: Revenue ($m) by Type, 2016 & 2017
  • Table 7.10 3M: Overview, 2017
  • Table 7.11 3M: Health Care Historical Revenue ($bn), AGR (%) and CAGR (%), 2013-2017
  • Table 7.12 BD: Overview, 2017
  • Table 7.13 BD: Drug Delivery Products by Segment, 2017
  • Table 7.14 BD: Historical Revenue ($bn) by Geographic Region, 2013-2017
  • Table 7.15 BD Medical: Historical Revenue ($bn), AGR (%) and CAGR (%), 2013-2017
  • Table 7.16 PharmaJet: Overview, 2017
  • Table 7.17 BioJect Medical Technologies: Overview, 2017
  • Table 7.18 Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
  • Table 7.19 Bioject Medical Technologies: Revenue ($m), AGR (%) and CAGR (%), 2010-2014
  • Table 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market, 2017-2028
  • Table 8.2 Average Price for Needle-Free Drug/Vaccine Delivery Technology, 2017

List of Figures

  • Figure 1.1 Global Needle-Free Delivery Technology Market Segmentation Overview, 2017
  • Figure 2.1 Percentage (%) of Needlestick Injuries during the Timeline of Use to Disposal of a Device
  • Figure 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2017-2028
  • Figure 3.2 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2017
  • Figure 3.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2022
  • Figure 3.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2028
  • Figure 3.5 Needle-Free Delivery Technology: Drivers and Restraints
  • Figure 4.1 The Jet Injectors Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 5.1 The Competing Needle-Free Technology Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 5.2 Market Shares (%) of Competing Needle-Free Technology Market Segments, 2017
  • Figure 5.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2022
  • Figure 5.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2028
  • Figure 5.5 Novel Needle Technology Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 5.6 Inhaler Technology Market: Revenue ($m), AGR (%), 2017-2028
  • Figure 5.7 Transdermal Patch Technology Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 6.1 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2017, 2022 and 2028
  • Figure 6.2 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2017-2022
  • Figure 6.3 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2022-2028
  • Figure 6.4 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2017-2028
  • Figure 6.5 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2017
  • Figure 6.6 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2022
  • Figure 6.7 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2028
  • Figure 6.8 US Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.9 EU5 Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), 2017-2028
  • Figure 6.10 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2017
  • Figure 6.11 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2022
  • Figure 6.12 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2028
  • Figure 6.13 Germany Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.14 France Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.15 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.16 Italy Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.17 Spain Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.18 Japan Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.19 China Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.20 India Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.21 RoW Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 7.1 Antares Revenue from Major Customers: Revenue Share (%), 2016
  • Figure 7.2 Antares Revenue from Major Customers: Revenue Share (%), 2017
  • Figure 7.3 Antares Revenue by Region: Revenue Share (%), 2016
  • Figure 7.4 Antares Revenue by Region: Revenue Share (%), 2017
  • Figure 7.5 Antares Pharma: Historical Revenue ($m) and AGR (%), 2013-2017
  • Figure 7.6 Zogenix: Revenue ($m) and AGR (%), 2013-2017
  • Figure 7.7 Zogenix: Revenue ($m) by Type, 2016
  • Figure 7.8 Zogenix: Revenue ($m) by Type, 2017
  • Figure 7.9 3M: Health Care Historical Revenue ($bn) and AGR (%), 2013-2017
  • Figure 7.10 BD: Historical Revenue ($bn) by Geographic Region, 2013-2017
  • Figure 7.11 BD Medical: Historical Revenue ($bn) and AGR (%), 2013-2015
  • Figure 7.12 Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
  • Figure 7.13 Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
  • Figure 8.1 The Transport Process for a Vaccine

COMPANIES LISTED

  • 3M
  • Actavis
  • Activa Brand Products
  • AcuShot
  • Adamis
  • Aktiv-Dry
  • Alkermes
  • Alza
  • Anesiva
  • Antares Pharma
  • Aradigm
  • Astellas Pharma
  • AstraZeneca
  • BD
  • BeadTek
  • Berlex Labs
  • Bespak
  • bioCSL
  • Bioject Medical Technologies
  • Biomedics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb and Somerset Pharmaceuticals
  • Cambridge Consultants
  • CareFusion Corporation
  • CEA-LETI
  • Corium International
  • CosMed
  • Crossject
  • CureVac
  • D'Antonio Consultants International
  • Debiotech
  • Durect
  • Echo Therapeutics
  • Elcam Medical
  • Eli Lilly & Co
  • Endo International
  • Ethical Holdings/Schering
  • Eurojet Medical
  • Ferndale
  • Georgia Institute of Technology
  • Giant Eagle
  • GlaxoSmithKline
  • Glide Pharmaceutical Technologies
  • Hangzhou Hema Medical Equipment
  • Haselmeir GmbH
  • Health-Mor Personal Care
  • Hirtenberger
  • Ichor
  • iHealthNet
  • Immunomic Therapeutics
  • ImmusanT
  • Injex Pharma
  • Inovio Pharmaceuticals
  • Invion
  • Janssen Pharmaceuticals
  • Key Pharmaceuticals
  • Kroger
  • LEO Pharma
  • LTS Lohmann Therapie-Systeme
  • MannKind
  • Mecaplast
  • Meda Pharmaceuticals
  • Medac Pharma
  • Medical International Technologies
  • Medi-Ject
  • MedImmune
  • Merck
  • Merck Serono
  • Micron Biomedical
  • Mylan
  • nanoBioSciences
  • NanoPass
  • Napp Pharmaceuticals
  • National Medical Products
  • Nektar Therapeutics
  • Nemaura
  • Nicobrand Limited
  • Novartis
  • Novo Nordisk
  • Novogyne Pharmaceuticals
  • NuPathe
  • Nycomed
  • Ortho-McNeil
  • Owen MumFord Inc
  • Par Pharmaceutical
  • Parke-Davis
  • Penjet Corporation
  • Permatec
  • Pernix
  • Pfizer
  • PharmaJet
  • PKA SoftTouch Corp
  • Procter & Gamble
  • ProStrakan
  • Purdue Pharma
  • Radius Health
  • Rhenovia Pharma
  • Rite Aid
  • Roche
  • Sandoz
  • Sanofi
  • Searle Pharmaceuticals
  • Shire
  • SHL Group AB
  • Shwarz-Pharma
  • Société Nationale des Poudres et Explosifs
  • STADA Arzneimittel AG
  • Stat Medical Devices
  • Takeda
  • Teva
  • Tev-Tropin
  • The Medical House
  • TheraJect
  • TheraTech
  • Transdermal Specialties
  • Trimeris
  • Trinity-Chiesi
  • UCB Pharma
  • University of California-San Francisco
  • Vaxxas
  • Vetter Pharma
  • Vyteris
  • Watson
  • West Pharmaceuticals
  • Westmount Pharmacy
  • Ypsomed AG
  • Zogenix
  • Zosano
  • Zydus Cadila

Organizations Mentioned in the report

  • Ankara University
  • Atlanta's Emory University
  • Bill & Melinda Gates Foundation
  • Gwangju Institute of Science and Technology
  • Indian Institute of Science, Bangalore
  • Massachusetts Institute of Technology
  • National University of Singapore
  • Oxford University
  • Seoul National University
  • Shibaura Institute of Technology
  • University of Texas
  • University of Wisconsin's Hospital

List of Tables

  • Table 2.1: Classification of Jet Injectors by Method of Propulsion
  • Table 2.2: Strengths and Weaknesses of the Jet Injector Market
  • Table 2.3: Pen Needle Technology by Needle Length
  • Table 2.4: Rationale for Needle-Free Vaccine Delivery
  • Table 2.5: Examples of Needle-Free Vaccine Delivery Systems, 2016
  • Table 2.6: Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2016
  • Table 2.7: FDA Guidance on Regulation of Needle-Free Injectors, 2015
  • Table 2.8: Top 5 Biologics by Sales ($bn), 2015
  • Table 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2015
  • Table 3.2: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 3.3: Needle-Free Delivery Market Segments: Market Size ($m) and Market Share (%), 2015, 2020 and 2026
  • Table 4.1: The Jet Injectors Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.1: The Competing Needle-Free Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.2: Market Size ($m) and Market Share (%) of Competing Needle-Free Technology Market Segments, 2015
  • Table 5.3: Novel Needle Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.4: Inhaler Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.5: Leading Products in the Asthma Preventer Inhaler Market, 2016
  • Table 5.6: Leading Products in the Asthma Reliever Inhaler Market, 2016
  • Table 5.7: Vaccine Inhalers Currently Under Development, 2016
  • Table 5.8: Transdermal Patch Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.9: Transdermal Patch Products, 2016
  • Table 6.1: Global Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%) by Region, 2015-2026
  • Table 6.2: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
  • Table 6.3: Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
  • Table 6.4: US Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.5: EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.6: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015, 2020 and 2026
  • Table 6.7: German Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.8: French Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.9: UK Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2015-2026
  • Table 6.10: Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.11: Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.12: Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.13: Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
  • Table 6.14: Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 7.1: Antares Pharma: Overview, 2016
  • Table 7.2: Antares Pharma: 2016 Product Portfolio (Product, Drug, Partner, Indication and Territory
  • Table 7.3: Antares Revenue from Major Customers: Revenue ($m) and Revenue Share (%), 2014 and 2015
  • Table 7.4: Antares Revenue by Region: Revenue ($m) and Revenue Share (%), 2014 and 2015
  • Table 7.5: Antares Pharma: Historical Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 7.6: Antares Pharma: Products in Development 2016 (Product Name, Drug, Partner, Indication, Territory and Regulatory Status)
  • Table 7.7: Zogenix: Overview, 2016
  • Table 7.8: Zogenix: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 7.9: Zogenix: Revenue ($m) by Type, 2010-2015
  • Table 7.10: 3M: Overview, 2016
  • Table 7.11: 3M: Health Care Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
  • Table 7.12: BD: Overview, 2016
  • Table 7.13: BD: Drug Delivery Products by Segment, 2016
  • Table 7.14: BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
  • Table 7.15: BD Medical: Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
  • Table 7.16: PharmaJet: Overview, 2016
  • Table 7.17: BioJect Medical Technologies: Overview, 2016
  • Table 7.18: Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
  • Table 7.19: Bioject Medical Technologies: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 8.1: SWOT Analysis of the Needle-Free Delivery Technology Market, 2016-2026
  • Table 8.2: Average Price for Needle-Free Drug/Vaccine Delivery Technology, 2015

List of Figures

  • Figure 1.1: Global Needle-Free Delivery Technology Market Segmentation Overview, 2015
  • Figure 2.1: Percentage (%) of Needlestick Injuries during the Timeline of Use to Disposal of a Device
  • Figure 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2015-2026
  • Figure 3.2: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2015
  • Figure 3.3: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
  • Figure 3.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
  • Figure 3.5: Needle-Free Delivery Technology: Drivers and Restraints 2016-2026
  • Figure 4.1: The Jet Injectors Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.1: The Competing Needle-Free Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.2: Market Shares (%) of Competing Needle-Free Technology Market Segments, 2015
  • Figure 5.3: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
  • Figure 5.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
  • Figure 5.5: Novel Needle Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.6: Inhaler Technology Market: Revenue ($m), AGR (%), 2015-2026
  • Figure 5.7: Transdermal Patch Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.1: Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
  • Figure 6.2: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2020
  • Figure 6.3: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2020-2026
  • Figure 6.4: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2026
  • Figure 6.5: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
  • Figure 6.6: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2020
  • Figure 6.7: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2026
  • Figure 6.8: US Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.9: EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%), 2015-2026
  • Figure 6.10: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015
  • Figure 6.11: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2020
  • Figure 6.12: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2026
  • Figure 6.13: German Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.14: French Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.15: UK Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.16: Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.17: Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.18: Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.19: Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.20: Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 7.1: Antares Revenue from Major Customers: Revenue Share (%), 2014
  • Figure 7.2: Antares Revenue from Major Customers: Revenue Share (%), 2015
  • Figure 7.3: Antares Revenue by Region: Revenue Share (%), 2014
  • Figure 7.4: Antares Revenue by Region: Revenue Share (%), 2015
  • Figure 7.5: Antares Pharma: Historical Revenue ($m) and AGR (%), 2010-2015
  • Figure 7.6: Zogenix: Revenue ($m) and AGR (%), 2010-2015
  • Figure 7.7: Zogenix: Revenue ($m) by Type, 2014
  • Figure 7.8: Zogenix: Revenue ($m) by Type, 2015
  • Figure 7.9: 3M: Health Care Historical Revenue ($bn) and AGR (%), 2010-2015
  • Figure 7.10: BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
  • Figure 7.11: BD Medical: Historical Revenue ($bn) and AGR (%), 2010-2015
  • Figure 7.12: Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
  • Figure 7.13: Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
  • Figure 8.1: The Transport Process for a Vaccine

Companies Listed

  • 3M
  • Actavis
  • Activa Brand Products
  • AcuShot
  • Adamis
  • Aktiv-Dry
  • Alkermes
  • Alza
  • Anesiva
  • Antares Pharma
  • Aradigm
  • Astellas Pharma
  • AstraZeneca
  • BD
  • BeadTek
  • Berlex Labs
  • Bespak
  • bioCSL
  • Bioject Medical Technologies
  • Biomedics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb and Somerset Pharmaceuticals
  • Cambridge Consultants
  • CareFusion Corporation
  • CEA-LETI
  • Corium International
  • CosMed
  • Crossject
  • CureVac
  • D'Antonio Consultants International
  • Debiotech
  • Durect
  • Echo Therapeutics
  • Elcam Medical
  • Eli Lilly & Co
  • Endo International
  • Ethical Holdings/Schering
  • Eurojet Medical
  • Ferndale
  • Georgia Institute of Technology
  • Giant Eagle
  • GlaxoSmithKline
  • Glide Pharmaceutical Technologies
  • Hangzhou Hema Medical Equipment
  • Haselmeir GmbH
  • Health-Mor Personal Care
  • Hirtenberger
  • Ichor
  • iHealthNet
  • Immunomic Therapeutics
  • ImmusanT
  • Injex Pharma
  • Inovio Pharmaceuticals
  • Invion
  • Janssen Pharmaceuticals
  • Key Pharmaceuticals
  • Kroger
  • LEO Pharma
  • LTS Lohmann Therapie-Systeme
  • MannKind
  • Mecaplast
  • Meda Pharmaceuticals
  • Medac Pharma
  • Medical International Technologies
  • Medi-Ject
  • MedImmune
  • Merck
  • Merck Serono
  • Micron Biomedical
  • Mylan
  • nanoBioSciences
  • NanoPass
  • Napp Pharmaceuticals
  • National Medical Products
  • Nektar Therapeutics
  • Nemaura
  • Nicobrand Limited
  • Novartis
  • Novo Nordisk
  • Novogyne Pharmaceuticals
  • NuPathe
  • Nycomed
  • Ortho-McNeil
  • Owen MumFord Inc
  • Par Pharmaceutical
  • Parke-Davis
  • Penjet Corporation
  • Pernix
  • Pfizer
  • PharmaJet
  • PKA SoftTouch Corp
  • Procter & Gamble
  • ProStrakan
  • Purdue Pharma
  • Radius Health
  • Rhenovia Pharma
  • Rite Aid
  • Roche
  • Sandoz
  • Sanofi
  • Searle Pharmaceuticals
  • Shire
  • SHL Group AB
  • Shwarz-Pharma
  • Société Nationale des Poudres et Explosifs
  • STADA Arzneimittel AG
  • Stat Medical Devices
  • Takeda
  • Teva
  • The Medical House
  • TheraJect
  • TheraTech
  • Transdermal Specialties
  • Trimeris
  • Trinity-Chiesi
  • UCB Pharma
  • University of California-San Francisco
  • Vaxxas
  • Vetter Pharma
  • Vyteris
  • Watson
  • West Pharmaceuticals
  • Westmount Pharmacy
  • Ypsomed AG
  • Zogenix
  • Zosano
  • Zydus Cadila

Organisations Mentioned in the Report

  • Ankara University
  • Atlanta's Emory University
  • Bill & Melinda Gates Foundation
  • Gwangju Institute of Science and Technology
  • Indian Institute of Science, Bangalore
  • Massachusetts Institute of Technology
  • National University of Singapore
  • Oxford University
  • Seoul National University
  • Shibaura Institute of Technology
  • University of Texas
  • University of Wisconsin's Hospital
Back to Top